Name | PROTAC ER Degrader-3 |
---|
Description | PROTAC ER Degrader-3 is an intermediate for synthesis of PAC. PAC comprises an antibody conjugated via a linker to a PROTAC. PAC extracts from patent WO2017201449A1, compound LP2. PAC is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab). |
---|---|
Related Catalog | |
References |
[1]. Thomas Pillow, et al. Protac antibody conjugates and methods of use. WO2017201449A1. |
Molecular Formula | C71H77N7O12 |
---|---|
Molecular Weight | 1220.41 |
Storage condition | 2-8℃ |